2014
DOI: 10.1136/bcr-2014-206710
|View full text |Cite
|
Sign up to set email alerts
|

Successful use of blood pleurodesis to resolve an iatrogenic persistent pneumothorax in a patient with pulmonary tuberculosis

Abstract: A Somali patient with previous tuberculosis presented clinically unwell with features consistent with a right-sided pleural effusion. Subsequent investigations confirmed a community-acquired pneumonia and relapse of pulmonary tuberculosis, with a drug resistant strain isolated. The patient developed a large left-sided iatrogenic pneumothorax, which recurred and failed to resolve despite the successful insertion of both Seldinger and surgical chest drains, and the patient remained clinically unstable on the int… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…Most evidence for the efficacy of ABPP is early after surgical lung resection. While its use has been described in the setting of active infection, the evidence is limited [9][10][11]18]. ABPP can also be utilized despite areas of pleural nonapposition [19].…”
Section: Casementioning
confidence: 99%
See 1 more Smart Citation
“…Most evidence for the efficacy of ABPP is early after surgical lung resection. While its use has been described in the setting of active infection, the evidence is limited [9][10][11]18]. ABPP can also be utilized despite areas of pleural nonapposition [19].…”
Section: Casementioning
confidence: 99%
“…EBVs are placed with a flexible bronchoscope in segmental or subsegmental bronchi to limit airflow to distal areas of the lung, while allowing mucus egress and airflow in proximal areas [8] permitting the BPF to heal with subsequent valve removal. Autologous blood patch pleurodesis (ABPP) has been used to address both secondary spontaneous pneumothoraces (SSPs) and PALs mainly after active pulmonary infection [9][10][11][12]. A portion of the patient's own blood is injected into their pleural space via a chest tube.…”
Section: Introductionmentioning
confidence: 99%